Enhabit, Inc. (NYSE:EHAB) Sees Large Drop in Short Interest

Enhabit, Inc. (NYSE:EHAB) saw a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 1,220,000 shares, a decrease of 5.4% from the December 15th total of 1,290,000 shares. Based on an average trading volume of 375,300 shares, the short-interest ratio is presently 3.3 days. Approximately 2.8% of the shares of the company are short sold.

Insider Buying and Selling at Enhabit

In other news, Director Jeffrey Bolton purchased 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The shares were acquired at an average price of $8.69 per share, for a total transaction of $34,760.00. Following the completion of the acquisition, the director now directly owns 98,144 shares in the company, valued at approximately $852,871.36. The trade was a 4.25 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Stuart M. Mcguigan bought 15,000 shares of the company’s stock in a transaction on Tuesday, December 10th. The shares were acquired at an average price of $8.81 per share, with a total value of $132,150.00. Following the transaction, the director now directly owns 46,810 shares in the company, valued at approximately $412,396.10. The trade was a 47.15 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 1.90% of the company’s stock.

Institutional Trading of Enhabit

Several hedge funds have recently added to or reduced their stakes in EHAB. FMR LLC raised its stake in Enhabit by 138.4% in the third quarter. FMR LLC now owns 3,388 shares of the company’s stock valued at $27,000 after purchasing an additional 1,967 shares in the last quarter. Quarry LP raised its holdings in Enhabit by 242.2% in the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after purchasing an additional 2,621 shares in the last quarter. Gladius Capital Management LP grew its stake in Enhabit by 78.2% in the third quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock worth $49,000 after purchasing an additional 2,747 shares during the period. Stoneridge Investment Partners LLC purchased a new position in shares of Enhabit during the third quarter valued at approximately $81,000. Finally, Canada Pension Plan Investment Board purchased a new position in shares of Enhabit in the 2nd quarter worth about $93,000.

Analysts Set New Price Targets

EHAB has been the topic of a number of research reports. Jefferies Financial Group raised shares of Enhabit from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $8.25 to $9.50 in a research report on Monday, December 9th. Leerink Partners reissued a “market perform” rating and issued a $8.00 price target (down from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, Enhabit presently has an average rating of “Hold” and a consensus target price of $8.75.

Enhabit Stock Up 0.2 %

Shares of NYSE:EHAB opened at $7.99 on Friday. Enhabit has a 1 year low of $6.85 and a 1 year high of $11.74. The business’s 50-day moving average is $7.83 and its 200-day moving average is $8.11. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The business had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. During the same period last year, the business posted $0.03 earnings per share. On average, research analysts anticipate that Enhabit will post 0.22 EPS for the current fiscal year.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.